
INACTIVE/DISSOLVED
Founded
10 Mar 2005
Address
Clarus Ventures LLC
One Memorial Drive
Suite 1230
Cambridge, MA 02142
United States
Phone
Website
VCID: 30972
Profile
Corporate information
Official name
Clarus Ventures LLC
Renamed to
Investment activity status
Not investing
Company type
Life sciences venture capital firmFunds managed
Fund | Type | Vintage |
---|---|---|
Clarus IV-A LP | Venture | 2017 |
Clarus IV-B LP | Venture | 2017 |
Clarus IV-C LP | Venture | 2017 |
Clarus IV-D LP | Venture | 2017 |
Clarus DE II LP | Venture | 2014 |
Clarus Defined Exit I LP | Venture | 2014 |
Clarus Lifesciences III LP | Venture | 2014 |
Clarus Ventures III GP LP | Venture | 2014 |
Clarus Lifesciences II LP | Venture | 2008 |
Clarus Lifesciences I LP | Venture | 2006 |
Clarus Ventures II | Venture |
Funding
Funding rounds
Investor | Profile | Country | Notes | |
---|---|---|---|---|
![]() |
The Blackstone Group LP | Private equity firm | United States | Led the round. |
Cap Table
Current and past shareholders
Investor | Contacts | Round | |
---|---|---|---|
![]() |
The Blackstone Group LP Private equity firm |
+1 (212) 583-5000 |
Acquisition |
Investments
Investment preferences
Selected investments
Company | Country | Date | Notes | ||
---|---|---|---|---|---|
![]() |
Oxford Immunotec Ltd |
United Kingdom | 1 Apr 2010 18 Jun 2012 |
Venture Round participant. Active |
|
![]() |
Flowonix Medical A medical device company dedicated to helping those who suffer from chronic disorders. |
United States | 1 May 2012 | N/A |
|
![]() |
Catabasis Pharmaceuticals Inc |
United States | 1 Apr 2010 1 Dec 2011 |
Series A |
|
![]() |
NanoString Technologies Inc A life sciences company, markets solutions for detecting and counting large sets of target molecules in biological samples for researchers. |
United States | 1 Jun 2009 1 Nov 2011 |
Series D Active |
|
![]() |
Cleave Biosciences Inc Drug development company focused on novel targets in cellular protein homeostasis pathways |
United States | 1 Oct 2011 | Series A Active |
|
![]() |
SARcode Bioscience Inc |
United States | 1 Jul 2011 | Series B |
|
![]() |
Aerie Pharmaceuticals Inc |
United States | 1 Mar 2011 | Series B Active |
|
![]() |
TyRx Inc |
United States | 1 Dec 2010 | N/A |
|
![]() |
Pearl Therapeutics Inc Developing unique dual and triple combination products for the treatment of widely prevalent respiratory diseases |
United States | 1 Feb 2010 | N/A |
|
![]() |
Zogenix Inc A pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. |
United States | 1 Sep 2009 | Series B Follow-on investment. Round participant. Active |
|
![]() |
Lycera Corp |
United States | 1 Apr 2009 | Series A |
|
![]() |
Aerovance Inc |
United States | 1 Apr 2009 | N/A Active |
|
![]() |
Heptares Therapeutics Ltd |
United Kingdom | 1 Feb 2009 | Series A |
|
![]() |
Virdante Pharmaceuticals Inc A privately held biopharmaceutical company focused on the development and commercialization of drugs for autoimmune and inflammatory disorders. |
United States | 31 Dec 2008 | Series A |
|
![]() |
Biolex Therapeutics Inc |
United States | 1 Oct 2008 | Series D Active |
|
![]() |
Link Medicine Inc Advancing disease-modifying technologies targeted at Alzheimer's, Parkinson's and other neurodegenerative diseases |
United States | 1 Sep 2008 | Series C |
|
![]() |
ESBATech AG Switzerland based Biomedical Research Unit of Alcon |
Switzerland | 1 Aug 2008 | Series B Initial investment. Round participant. Active |